Tuesday, March 07, 2017 7:44:29 PM
As far as dilution; nonsense. It's only an issue for those who thought they were going to be millionaires on a $10K investment and were naive to the incredible work and stick to it-iveness it would take for this little company to bring DCVax to market. Don't blame the company for your greed and delusional expectations. Did NWBO ever say, "hey, investors, keep buying this stuff we're going to make you all filthy rich"? No, they tried to show positive results just like any other small early stage biologic company and put it in a good light to keep the machine rolling. The early data was as good a data as any company in a similar situation would be doing. Everything NWBO has done has been in front of the public and of regulators, all of it. To complain the Most Favored Nation Status was bogus, or that Linda Powers was lining her pockets with ill gotten $$ through Cognate is sour grapes and plain stupid. It was all there for anyone to see and investigate and think about. If you thought it was a great investment that's on you and no one else. But there are some of us who've been here very long term that still believe this is a viable and extraordinary product that will get to approval; all this speculation, grinding numbers, bitching, drawing diagrams and graphs, watching videos, etc., etc., etc., is nothing but people who can't cut through the crap and see the forest through the trees that have been planted by everyone and their brother on this board.
People who do enough D and D to see but not so much that they squirm around every little detail or setback are who win in biotech. There's over 100 billion dollars spent on Cancer worldwide every year. DCVax even remotely working in GBM validates a much wider perspective and use over the coming 10 years that could mean in less than 3 years NWBO could be a $20 Billion dollar company, on it's way to more. That could accommodate 500 million shares (a hell of an increase in your fearful "dilution" scenario) and still have a share price of $40. On an average price point of even $5/share initial investment of 10,000 shares ($50,000) that's $4 million dollars. Not enough for you? You wanted $40 million? Who's reality is that?
Who do you think pays the $1 million/year salaries of the Juno guys who showed a $245 million dollar loss in 2016? Jesus? Blame all you want; some crazy shit happened to NWBO that maybe they could have handled better, but maybe it was absolutely unavoidable and they did an amazing job of staying afloat while armchair experts sit on this board and whine about what idiots Linda and Les are.
That kind of hand wringing, off based analysis of an intense situation is what people who don't know or understand what they're doing, do.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM